Things categorized as 'funding'
Lycera Closes $36 Million Series A
Lycera announced the closing of a $36M Series A round of funding. The company is developing novel small-molecule pharmaceuticals to treat autoimmune diseases such as ...
Proteon Therapeutics Has A Big Day
Proteon Therapeutics announced it has successfully completed a $38 million Series B equity financing, started a Phase 1/2 clinical trial with its lead product, PRT-201, ...
Vertex to Buy Hepatitis C Drug Developer ViroChem for $375M
Vertex, which is developing the hepatitis C virus (HCV) protease inhibitor telaprevir, will add two polymerase inhibitors to its HCV drug development portfolio through an ...
Heptares Secures $30M in Series A Funding
Heptares Therapeutics, the drug discovery company focused on drugs targeting G-protein-coupled receptors (GPCRs), annnouced it has raised $30M (GBP21M) of equity finance in a successful ...
Idenix Take $34M Upfront From GSK For IDX899
Idenix and GlaxoSmithKline announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899. Terms -------------------------------- Upfront: $34M ($17M in cash; $17M equity stake ...
Symphogen Nets $44M in Financing
The Copenhagen based Symphogen announced the closing of a € 33 million (approximately U.S. $44 million) financing. Existing investors participated in the round, ...
Hydra Biosciences Raises $22 Million in Series D Financing
Hydra Biosciences raised $22.2 million in a Series D financing led by MedImmune Ventures, a wholly-owned venture capital fund of MedImmune, the biologics business of ...
Kolltan Raises over $35 Million in Series A Haul
Kolltan Pharmaceuticals, which in my opinion sounds like the name of a cartoon villian, has raised over $35 million in its Series A preferred stock ...
Vivaldi Biosciences Nets $23M in Series A Round
Vivaldi Biosciences, developing live attenuated vaccines for influenza, announced that it has received commitments for $23 million in a Series A Read More →
Anaphore Announces $25 Million Series A Financing
Anaphore announced it has raised $25 million in Series A financing led by 5AM Ventures, Versant Ventures, and Apposite Capital. Not a bad haul for ...
Numerate Completes $4 Million Series A
Numerate, a biotechnology company leveraging a novel drug engineering process to design lead-stage drug compounds, announced today that it has completed a $4 million Series ...
Zafgen Raises $14 Million in Series B
ZafGen, a Cambridge-based developer of an obesity therapy based on the vascular targeting of adipose tissue, has raised $14 million in Series B funding, according ...
Pacira Pharmaceuticals Raises $85 Million in Series A
Pacira Pharmaceuticals, a San Diego based maker of controlled-release injectable products, has expanded its Series A round to $85 ...
Accera Completes $35 Million Series C Financing
Accera announced it has recently closed a Series C financing round of $35 million (euro 27 million), led by Inventages Venture Capital SA. The company ...
TorreyPines Sells Alzheimer’s Disease Genetics Program to Eisai
TorreyPines Therapeutics, Inc. today announced that it has agreed to sell its Alzheimer's disease genetics research program to Eisai Co., Ltd. for an upfront cash ...